Effects of intravitreal anti-VEGF therapy of kidney function in patients treated for proliferative diabetic retinopathy

From Michael Hawkes June 4th, 2020

6 plays 0 comments

Dr Ashley Neiweem discusses the effects of intravitreal anti-VEGF (vascular endothelial growth factor) on kidney function in patients with proliferative diabetic retinopathy.

Tags: diabetic retinopathykidney functionvitreousretinaophthalmology and ophthalmopathy

Appears In: 2020 Ophthalmology Trainees' Day Retina at Indiana University